Exhibition Stands > News

Novo Nordisk re-elects board members

19 Mar 2009

Changes to Novo Nordisk''s board of directors were announced at the pharmaceutical company''s annual general meeting (AGM) this week.

Sten Scheibye, Goran A Ando, Pamela J Kirby, Kurt Anker Nielsen, Henrik Gurter and Jorgen Wedel were re-elected, while Hannu Ryopponen will join the team for the first time.

Also discussed at the AGM was the re-election of Novo Nordisk''s auditor, which remains as PricewaterhouseCoopers.

Distribution of profit was confirmed, in accordance with the Annual Report 2008. A dividend of six Danish kroner (76 pence) per share of one Danish kroner represents an increase of 33 per cent, the company said.

The announcements follow Novo Nordisk''s financial statement, which was released at the end of January.

Highlights of the report included a 21 per cent sales increase in international operations, a 13 per cent rise in net profit and a 16 per cent hike in earnings per share.

The company currently runs two offices in the UK and Ireland, located in Crawley and Dublin.